Role of cardiac magnetic resonance imaging in assessing ischemic and nonischemic cardiomyopathies

References

• Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation121(7), e46–e215 (2010).
   PubMed Web of Science ®Google Scholar
• Richardson P, Mckenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation93(5), 841–842 (1996).
   PubMed Web of Science ®Google Scholar
• Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J.29(2), 270–276 (2008).
   PubMed Web of Science ®Google Scholar
• Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation113(14), 1807–1816 (2006).
   PubMed Web of Science ®Google Scholar
• Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol.90(1), 29–34 (2002).
   PubMed Web of Science ®Google Scholar
• Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am. Heart J.147(2), 218–223 (2004).
   PubMed Web of Science ®Google Scholar
• Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson.8(3), 417–426 (2006).
   PubMed Web of Science ®Google Scholar
• Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur. Heart J.27(23), 2879–2888 (2006).
   PubMed Web of Science ®Google Scholar
• Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J. Am. Coll. Cardiol.44(6), 1164–1171 (2004).
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J. Am. Coll. Cardiol.51(16), 1581–1587 (2008).
   PubMed Web of Science ®Google Scholar
• Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation104(10), 1101–1107 (2001).
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J. Am. Coll. Cardiol.53(17), 1475–1487 (2009).
   PubMed Web of Science ®Google Scholar
• Schulz-Menger J, Wassmuth R, Abdel-Aty H et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart92(3), 399–400 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J.22(23), 2171–2179 (2001).
   PubMed Web of Science ®Google Scholar
• Gotte MJ, Germans T, Russel IK et al. Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function. J. Am. Coll. Cardiol.48(10), 2002–2011 (2006).
   Web of Science ®Google Scholar
• Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med.343(20), 1445–1453 (2000).
   PubMed Web of Science ®Google Scholar
• Plein S, Radjenovic A, Ridgway JP et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology235(2), 423–430 (2005).
   PubMed Web of Science ®Google Scholar
• Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J. Am. Coll. Cardiol.50(14), 1343–1353 (2007).
   PubMed Web of Science ®Google Scholar
• Nagel E, Klein C, Paetsch I et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation108(4), 432–437 (2003).
   PubMed Web of Science ®Google Scholar
• Schwitter J, Wacker CM, Van Rossum AC et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur. Heart J.29(4), 480–489 (2008).
   PubMed Web of Science ®Google Scholar
• Rieber J, Huber A, Erhard I et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur. Heart J.27(12), 1465–1471 (2006).
   Google Scholar
• Cury RC, Shash K, Nagurney JT et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation118(8), 837–844 (2008).
   PubMed Web of Science ®Google Scholar
• Aletras AH, Tilak GS, Natanzon A et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation113(15), 1865–1870 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt A, Azevedo CF, Cheng A et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation115(15), 2006–2014 (2007).
   PubMed Web of Science ®Google Scholar
• Deneke T, Muller KM, Lemke B et al. Human histopathology of electroanatomic mapping after cooled-tip radiofrequency ablation to treat ventricular tachycardia in remote myocardial infarction. J. Cardiovasc. Electrophysiol.16(11), 1246–1251 (2005).
   PubMed Web of Science ®Google Scholar
• Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation92(5), 1117–1125 (1995).
   PubMed Web of Science ®Google Scholar
• Mccrohon JA, Moon JC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation108(1), 54–59 (2003).
   PubMed Web of Science ®Google Scholar
• Casolo G, Minneci S, Manta R et al. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. Am. Heart J.151(1), 101–108 (2006).
   Google Scholar
• Soriano CJ, Ridocci F, Estornell J, Jimenez J, Martinez V, De Velasco JA. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J. Am. Coll. Cardiol.45(5), 743–748 (2005).
   PubMed Web of Science ®Google Scholar
• Assomull RG, Shakespeare C, Kalra PR et al. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation124(12), 1351–1360 (2011).
   Web of Science ®Google Scholar
• Stuber M, Weiss RG. Coronary magnetic resonance angiography. J. Magn. Reson. Imaging26(2), 219–234 (2007).
   Google Scholar
• Beek AM, Kuhl HP, Bondarenko O et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J. Am. Coll. Cardiol.42(5), 895–901 (2003).
   PubMed Web of Science ®Google Scholar
• Selvanayagam JB, Kardos A, Francis JM et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation110(12), 1535–1541 (2004).
   PubMed Web of Science ®Google Scholar
• Ichikawa Y, Sakuma H, Suzawa N et al. Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. Improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J. Am. Coll. Cardiol.45(6), 901–909 (2005).
   Web of Science ®Google Scholar
• Bello D, Fieno DS, Kim RJ et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J. Am. Coll. Cardiol.45(7), 1104–1108 (2005).
   PubMed Web of Science ®Google Scholar
• Roes SD, Kelle S, Kaandorp TA et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am. J. Cardiol.100(6), 930–936 (2007).
   PubMed Web of Science ®Google Scholar
• Cheong BY, Muthupillai R, Wilson JM et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation120(21), 2069–2076 (2009).
   PubMed Web of Science ®Google Scholar
• Kwong RY, Chan AK, Brown KA et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation113(23), 2733–2743 (2006).
   PubMed Web of Science ®Google Scholar
• Bodi V, Sanchis J, Nunez J et al. Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc. Imaging2(7), 835–842 (2009).
   PubMed Web of Science ®Google Scholar
• Klem I, Shah DJ, White RD et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ. Cardiovasc. Imaging4(6), 610–619 (2011).
   PubMedGoogle Scholar
• Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation97(8), 765–772 (1998).
   PubMed Web of Science ®Google Scholar
• De Waha S, Desch S, Eitel I et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur. Heart J.31(21), 2660–2668 (2010).
   PubMed Web of Science ®Google Scholar
• Hombach V, Grebe O, Merkle N et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur. Heart J.26(6), 549–557 (2005).
   PubMed Web of Science ®Google Scholar
• Yan AT, Shayne AJ, Brown KA et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation114(1), 32–39 (2006).
   PubMed Web of Science ®Google Scholar
• Larose E, Ganz P, Reynolds HG et al. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J. Am. Coll. Cardiol.49(8), 855–862 (2007).
   PubMed Web of Science ®Google Scholar
• White JA, Yee R, Yuan X et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J. Am. Coll. Cardiol.48(10), 1953–1960 (2006).
   PubMed Web of Science ®Google Scholar
• Chalil S, Foley PW, Muyhaldeen SA et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace9(11), 1031–1037 (2007).
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation97(18), 1802–1809 (1998).
   PubMed Web of Science ®Google Scholar
• Abdel-Aty H, Boye P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J. Am. Coll. Cardiol.45(11), 1815–1822 (2005).
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation109(10), 1250–1258 (2004).
   PubMed Web of Science ®Google Scholar
• Desai MY, Ommen SR, Mckenna WJ, Lever HM, Elliott PM. Imaging phenotype versus genotype in hypertrophic cardiomyopathy. Circ. Cardiovasc. Imaging4(2), 156–168 (2011).
   Google Scholar
• Austin BA, Kwon DH, Smedira NG, Thamilarasan M, Lever HM, Desai MY. Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. J. Am. Soc. Echocardiogr.22(1), 105.e105–e106 (2009).
   Google Scholar
• Kwon DH, Setser RM, Thamilarasan M et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart94(10), 1295–1301 (2008).
   PubMed Web of Science ®Google Scholar
• Maron MS, Olivotto I, Harrigan C et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation124(1), 40–47 (2011).
   PubMed Web of Science ®Google Scholar
• Kwon DH, Setser RM, Popovic ZB et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int. J. Cardiovasc. Imaging24(6), 617–625 (2008).
   Google Scholar
• O’Hanlon R, Grasso A, Roughton M et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.56(11), 867–874 (2010).
   PubMed Web of Science ®Google Scholar
• Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson–Fabry disease. J. Cardiovasc. Magn. Reson.8(3), 479–482 (2006).
   PubMed Web of Science ®Google Scholar
• Rochitte CE, Oliveira PF, Andrade JM et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J. Am. Coll. Cardiol.46(8), 1553–1558 (2005).
   PubMed Web of Science ®Google Scholar
• Petersen SE, Selvanayagam JB, Wiesmann F et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J. Am. Coll. Cardiol.46(1), 101–105 (2005).
   PubMed Web of Science ®Google Scholar
• Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force criteria. Circulation121(13), 1533–1541 (2010).
   PubMed Web of Science ®Google Scholar
• Tandri H, Castillo E, Ferrari VA et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J. Am. Coll. Cardiol.48(11), 2277–2284 (2006).
   PubMed Web of Science ®Google Scholar
• Feng D, Glockner J, Kim K et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation124(17), 1830–1837 (2011).
   PubMed Web of Science ®Google Scholar
• Silva MC, Meira ZM, Gurgel Giannetti J et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J. Am. Coll. Cardiol.49(18), 1874–1879 (2007).
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Gdynia HJ, Baccouche H et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J. Cardiovasc. Magn. Reson.10, 50 (2008).
   Google Scholar
• Gabriel RS, Renapurkar R, Bolen MA et al. Comparison of severity of aortic regurgitation by cardiovascular magnetic resonance versus transthoracic echocardiography. Am. J. Cardiol.108(7), 1014–1020 (2011).
   Google Scholar
• Bolen MA, Popovic ZB, Rajiah P et al. Cardiac MR assessment of aortic regurgitation: holodiastolic flow reversal in the descending aorta helps stratify severity. Radiology260(1), 98–104 (2011).
   Google Scholar
• Nazarian S, Bluemke DA, Lardo AC et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation112(18), 2821–2825 (2005).
   PubMed Web of Science ®Google Scholar
• Wu KC, Weiss RG, Thiemann DR et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol.51(25), 2414–2421 (2008).
   PubMed Web of Science ®Google Scholar
• Assomull RG, Prasad SK, Lyne J et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J. Am. Coll. Cardiol.48(10), 1977–1985 (2006).
   PubMed Web of Science ®Google Scholar
• Choudhury L, Mahrholdt H, Wagner A et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.40(12), 2156–2164 (2002).
   PubMed Web of Science ®Google Scholar
• Bruder O, Wagner A, Jensen CJ et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.56(11), 875–887 (2010).
   PubMed Web of Science ®Google Scholar
• Ruberg FL, Appelbaum E, Davidoff R et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am. J. Cardiol.103(4), 544–549 (2009).
   PubMed Web of Science ®Google Scholar
• Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J. Cardiovasc. Magn. Reson.10, 54 (2008).
   PubMed Web of Science ®Google Scholar
• Austin BA, Tang WH, Rodriguez ER et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc. Imaging2(12), 1369–1377 (2009).
   PubMed Web of Science ®Google Scholar
• Kirk P, Roughton M, Porter JB et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation120(20), 1961–1968 (2009).
   PubMed Web of Science ®Google Scholar